Enrichment of allogeneic tumor antigen-specific T cells from bone marrow (BM) of patients treated with high-dose post-transplant cyclophoshamide (Cy): A novel approach to adoptive immunotherapy.
K. Noonan
No relevant relationships to disclose
L. Luznik
No relevant relationships to disclose
I. Borrello
No relevant relationships to disclose